Sofinnova Raises €333m For European Biotech Fund

Venture Capital Firm’s Funds Worth €2bn

 
• By Andrew McConaghie
  
Paris
Paris-based Sofinnova attracted investors from Europe and beyond
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip